Treatment with non-automated insulin pumps or multiple daily injections during pregnancy and post-delivery in women with type 1 diabetes: A secondary analysis of the CopenFast trial
Despite routine use of CGM and similar glycaemic control, non-automated insulin pump users did not achieve improved pregnancy outcomes compared to MDI users.
Authors
- Kirsten Nørgaard (ORCID: https://orcid.org/0000-0003-1620-8271)
- Elisabeth R. Mathiesen (ORCID: https://orcid.org/0000-0003-3279-0863)
- Sidse Kjærhus Nørgaard (ORCID: https://orcid.org/0000-0002-6664-5755)
- Lene Ringholm (ORCID: https://orcid.org/0000-0003-2971-8043)
- Peter Damm (ORCID: https://orcid.org/0000-0002-2067-5246)
- Tine D. Clausen (ORCID: https://orcid.org/0000-0001-5585-2153)
- K. Christiansen (ORCID: https://orcid.org/0009-0002-4548-9703)
Institutions
- University of Copenhagen (DK)
- Steno Diabetes Centers (DK)
- Novo Nordisk (Denmark) (DK)
- Copenhagen University Hospital (DK)
- Rigshospitalet (DK)
Publication Details
- Journal
- Acta Diabetologica
- Published
- 2025-08-04
- DOI
- https://doi.org/10.1007/s00592-025-02560-w
- Primary Topic
- Diabetes Management and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00